About CMIC, Inc.
A global Contract Research Organization (CRO) with over 30 years of experience, CMIC’s skilled researchers provide cutting-edge expertise in small and large molecule bioanalysis to optimize drug development for pharmaceutical companies. We offer bioanalysis for non-clinical and clinical projects, both GLP and non-GLP, to meet critical drug development milestones. CMIC's GLP compliant state-of-the-art facility has the capacity to accommodate quick turnaround and high-volume projects from around the country.
|
|
|
51-200 employees
View all CMIC, Inc. employees
|
|
Biotechnology Research
|
|
2860 Forbs Avenue,Hoffman Estates,IL,US
|
|
Quantitative Assays Using Hplc, Lc-Ms/Ms, Elisa, Msd:, Method Development, Method Transfer, Method Qualification, Method Validation, Cross Validation, Sample Analysis
|
CMIC, Inc. Alternatives
Frequently Asked Questions about CMIC, Inc.
Ra'yya Mucmin is the CEO of CMIC, Inc..
The decision makers in CMIC, Inc. are Ra'yya Mucmin, Denise Funk, Angela G Stoyanovitch, etc. Click to Find CMIC, Inc. decision makers emails.
CMIC, Inc. Staff Directory
Search CMIC, Inc. Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
